去纤苷哪里有卖的？

Defibrinoside sodium () is a polydeoxyribose ribonate that has certain fibrinolytic and antithrombotic activities and can promote the production of prostacyclin-like substances and release them from vascular tissues into the circulation. This medicine is indicated for the treatment of adult and pediatric patients with hepatic venous occlusion (VOD) and associated renal or pulmonary abnormalities after blood or bone marrow hematopoietic stem cell transplantation (HSCT).

Defibrotide is currently the only FDA-approved treatment for adult and pediatric patients who develop hepatic venule occlusion (VOD) and associated renal or pulmonary abnormalities after blood or bone marrow hematopoietic stem cell transplantation (HSCT). Although safety data from randomized controlled trials are insufficient, available efficacy data confirm that defibrotide sodium significantly improves survival after 100 days.

The recommended dose for adult and pediatric patients is 6.25 mg/kg given as a 2-hour intravenous infusion every 6 hours. The dose should be based on the patient's baseline weight, which is defined as the patient's weight before the HSCT (hematopoietic stem cell transplant) preparation protocol. Defibrotide was administered for a minimum of 21 days. If signs and symptoms of hepatic veno-occlusive disease have not resolved after 21 days, continue defibrotide until resolution of hepatic veno-occlusive disease or for a maximum of 60 days.

Where can I buy it? Currently, defibrotide is not on the market in China, so it will not be included in China's medical insurance catalog to provide everyone with preferential medical insurance policies. Patients who want to purchase defibrotide can only go abroad to purchase defibrotide at their own expense. However, as we all know, the price of original drugs is very expensive, and a lot of manpower and material resources are consumed in the process of purchasing drugs, which puts huge pressure on patients. Therefore, more people choose to purchase drugs overseas to obtain the drugs they need. According to what Medical Companion Travel currently knows, the specification of defibrinoside is 200 mg, and the price is about $21,600. It is more suitable for patients to use for a long time, is high quality and low price, and saves worry and effort. The exchange rate in the market often fluctuates, and the price is not always fixed, but will change with the exchange rate. For more information about defibrotide, please contact Medical Travel for details.

Note: The above information comes from the Internet and is compiled and edited by Medical Companion Travel (please correct me if there are any errors or omissions). It is only to provide information on the latest drugs on the market in the world and help Chinese patients understand the latest international new drug trends. It is only for internal discussion among medical staff and does not serve as any basis for medication. For specific medication guidelines, please consult the attending physician.

Recommended related articles: